Clomifene Citrate: An Alternative Treatment for Male Low Testosterone

Testosterone replacement therapy (TRT) is the standard treatment for low testosterone, but it isn’t the right fit for every man, particularly those who want to preserve fertility. Clomifene citrate for men is an off-label option that works differently: rather than supplying testosterone directly, it stimulates the body to produce more of its own. This article explains how clomifene works, who it tends to suit, and what the evidence says about its effectiveness and safety.

Why TRT Isn’t Always the Right Starting Point

TRT, delivered via gels, injections, or pellets, supplies testosterone directly and often improves symptoms within weeks. But because the body senses adequate testosterone from the medication, it scales back its own production through the hypothalamic-pituitary-gonadal (HPG) axis, the feedback loop that normally regulates hormone output. Over time, this can reduce sperm production, and in some men, testicular size.

This is the main reason TRT is often avoided or used cautiously in men who are actively trying to conceive. It also requires long-term commitment: stopping TRT typically causes a drop back toward pre-treatment levels, since natural production has been suppressed throughout treatment.

What Is Clomifene Citrate, and How Does It Work?

Clomifene citrate is a selective oestrogen receptor modulator (SERM), originally developed for female infertility. Used off-label in men, it works by blocking oestrogen receptors in the hypothalamus and pituitary gland. Normally, oestrogen (partly converted from testosterone) signals the brain to ease off hormone production. By blocking that feedback, clomifene prompts the pituitary to release more luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn stimulates the testes to produce more testosterone naturally.

Because it works upstream of the testes rather than replacing testosterone directly, clomifene stimulates the body’s own production rather than substituting for it, which is why it doesn’t carry the same fertility-suppressing effect as TRT.

Who Clomifene Citrate Tends to Suit

Clomifene is generally considered for men with secondary hypogonadism, where testosterone is low but LH and FSH are also low or normal, indicating the testes themselves are still capable of responding to signalling. It’s typically not appropriate for primary hypogonadism, where the testes aren’t responding regardless of signal strength, since clomifene has nothing to stimulate in that scenario.

Men most likely to be considered for clomifene include those with secondary hypogonadism who want to preserve fertility, and men who are hesitant about the injection schedules or monitoring requirements associated with TRT. It’s generally avoided in men with a history of prostate cancer or significant liver disease.

What the Evidence Shows

Research on clomifene for male hypogonadism has grown substantially over the past decade. A 2021 systematic review and meta-analysis found that clomifene citrate meaningfully raises testosterone levels in hypogonadal men while largely preserving semen parameters, supporting its use as a fertility-sparing alternative to TRT.

Longer-term data is more limited but encouraging. One retrospective study following men on clomifene for more than three years found that the majority achieved normal testosterone levels and reported improved symptoms, with a small minority experiencing side effects. A separate randomised study found clomifene and hCG (another fertility-preserving option) similarly effective at restoring testosterone over a short course.

It’s worth noting that clomifene is not FDA-approved for use in men; all use for male hypogonadism is off-label, guided by the growing body of clinical research rather than a formal male-specific licence. This is common practice in men’s hormonal health but is worth understanding before starting treatment.

Potential Side Effects of Clomifene Citrate

Clomifene is generally well tolerated, but it isn’t free of side effects. The most commonly reported include mood changes, headaches, and mild breast tenderness related to shifting oestrogen levels. Visual disturbances have been reported rarely and typically resolve after stopping the medication.

Long-term studies haven’t identified the same red blood cell (polycythemia) concerns commonly monitored with TRT, but clomifene still requires regular bloodwork, typically testosterone, oestradiol, and LH/FSH, to guide dosing and catch any issues early. As with any hormonal therapy, “well tolerated” doesn’t mean risk-free, and ongoing monitoring is part of using it safely.

A Programme Built Around You

At PrimeLife, clomifene is one option within a broader men’s health programme, considered alongside TRT and other treatments based on your bloodwork, fertility goals, and health history. Every patient has a consultation with a qualified prescriber, and where clomifene is appropriate, treatment includes regular monitoring to track response and adjust dosing safely.

If preserving fertility is a priority while addressing low testosterone, it’s worth finding out whether clomifene is a fit for you.

Men’s Health programme

Book a consultation

Further Reading

• Huijben, M., et al. (2021). Clomifene citrate for men with hypogonadism: a systematic review and meta-analysis. Andrology.
• Krzastek, S. C., et al. (2019). Long term safety and efficacy of clomifene citrate for the treatment of hypogonadism. Journal of Urology.
• Habous, M., et al. (2018). Clomifene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study. BJU International.
• Ide, V., et al. (2020). Treatment of men with central hypogonadism: alternatives for testosterone replacement therapy. Andrology.